Paul R. Vigano, recognized as a ten percent owner of Aveanna Healthcare Holdings, Inc. (NASDAQ:AVAH), disclosed that entities under his influence completed the sale of common stock worth approximately $24.03 million on June 30, 2026. These transactions were executed at a consistent price of $8.01 per share. The company's stock has since appreciated to $9.22, marking a 99% return over the previous year. Current valuation metrics from InvestingPro analysis suggest the shares are trading close to their Fair Value of $9.65, supported by an "EXCELLENT" financial health score.
The disposition involved an indirect transfer of 3,000,000 shares. J.H. Whitney VII, L.P. was responsible for selling 2,419,035 shares, while JHW Iliad Holdings LLC disposed of 525,844 shares, and JHW Iliad Holdings II LLC sold 55,121 shares. Mr. Vigano's connection to these entities arises from his positions as Managing Member of J.H. Whitney Equity Partners VII, LLC, Member of Project Iliad Managing Member, LLC, and Senior Managing Director of J.H. Whitney Capital Partners, LLC. These roles grant him potential voting and dispositive power over the shares, though he explicitly disclaims beneficial ownership except for his pecuniary interest.
Post-transaction, the affiliated entities continue to hold significant stakes. J.H. Whitney VII, L.P. retains 10,112,123 shares, PSA Healthcare Investment Holdings LLC holds 15,523,810 shares, JHW Iliad Holdings LLC maintains 1,813,795 shares, PSA Iliad Holdings LLC keeps 1,426,034 shares, and JHW Iliad Holdings II LLC holds 190,130 shares. Mr. Vigano personally holds no direct shares. The stock data indicates a real-time price of 9.17, reflecting a +0.310 (+3.50%) change, with historical performance charts available for analysis.
In parallel corporate developments, Aveanna Healthcare completed the acquisition of Family First Holding, LLC for $175.5 million in cash. This transaction adds 27 locations across seven states to Aveanna's portfolio, enhancing its pediatric home care services. The deal was funded using cash on hand, further expanding the company's platform scale. Additionally, RBC Capital upgraded Aveanna Healthcare's stock rating to Outperform from Sector Perform, citing solid execution on preferred payor relationships. Moody's Ratings also upgraded Aveanna's corporate family rating to B2 from B3, reflecting improved business performance and reduced leverage. The senior secured first lien bank credit facility rating was similarly upgraded to B2. Furthermore, Aveanna announced a repricing of its first lien credit facility and revolving credit facility, reducing applicable interest rate margins by 50 basis points. These developments highlight strategic growth and financial adjustments within the healthcare sector.